Download PDF
Thromb Haemost 1992; 68(03): 374
DOI: 10.1055/s-0038-1656384
Letters to the Editor
Schattauer GmbH Stuttgart

Plasminogen Activator Inhibitor-2 and Alpha-Fetoprotein in Various Liver Disease States

E Özyılkan (Ünlü)
Hacettepe University Medical Center, Department of Internal Medicine, Division of Gastroenterology and Hematology, Ankara, Turkey
,
H Şimşek
Hacettepe University Medical Center, Department of Internal Medicine, Division of Gastroenterology and Hematology, Ankara, Turkey
,
O Özdemir
Hacettepe University Medical Center, Department of Internal Medicine, Division of Gastroenterology and Hematology, Ankara, Turkey
,
B Sivri
Hacettepe University Medical Center, Department of Internal Medicine, Division of Gastroenterology and Hematology, Ankara, Turkey
,
Ş Kirazlı
Hacettepe University Medical Center, Department of Internal Medicine, Division of Gastroenterology and Hematology, Ankara, Turkey
,
H Telatar
Hacettepe University Medical Center, Department of Internal Medicine, Division of Gastroenterology and Hematology, Ankara, Turkey
› Author Affiliations
Further Information

Publication History

Received 24 March 1992

Accepted 10 April 1992

Publication Date:
04 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Lecander I, Åstedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol 1986; 62: 221-228
    CrossrefPubMedGoogle Scholar
  • 2 Åstedt B, Lecander I, Ny T. The placental type plasminogen activator inhibitor, PAI-2. Fibrinolysis 1987; 1: 203-208
    PubMedGoogle Scholar
  • 3 Åstedt B, Hagerstrand I, Lecander I. Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemostas 1986; 56: 63-65
    PubMedGoogle Scholar
  • 4 Kruithof EKO, Gudinchet A, Bachmann F. Plasminogen activator inhibitor 1 and plasminogen activator 2 in various disease states. Thromb Haemostas 1988; 59: 07-12
    PubMedGoogle Scholar
  • 5 Tran-Thang C, Fasel-Felley J, Pralong G. et al Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism and infectious hepatitis. Thromb Haemostas 1989; 62: 651-653
    PubMedGoogle Scholar
  • 6 Bates SE, Longo DL. Use of serum tumor markers in cancer diagnosis and management. Semin Oncol 1987; 14: 102-138
    PubMedGoogle Scholar
  • 7 Waldmann TA, McIntire KR. The use of radioimmunoassay for alpha-fetoprotein in the diagnosis of malignancy. Cancer 1974; 34: 1510-1515
    CrossrefPubMedGoogle Scholar
  • 8 Wepsic HT. Alpha-fetoprotein: Its quantitation and relationship to neoplastic disease. Alpha-fetoprotein. Laboratory Procedures and Clinical Applications Kirkpatrick AM, Nakamura RM. Masson, New York: 1981: 115-29
    Google Scholar